ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205,191 | -12.8% | 68,397 | +8.7% | 0.00% | – |
| Q2 2023 | $235,235 | +13.1% | 62,897 | +1.1% | 0.00% | – |
| Q1 2023 | $208,000 | +20494.1% | 62,213 | -70.4% | 0.00% | – |
| Q4 2022 | $1,010 | -99.9% | 210,018 | +13.5% | 0.00% | – |
| Q3 2022 | $1,053,000 | +232.2% | 185,044 | +314.9% | 0.00% | – |
| Q2 2022 | $317,000 | -80.0% | 44,605 | -79.7% | 0.00% | – |
| Q1 2022 | $1,586,000 | +285.9% | 219,600 | +378.2% | 0.00% | – |
| Q4 2021 | $411,000 | -73.3% | 45,920 | +4.7% | 0.00% | – |
| Q3 2021 | $1,537,000 | +157.9% | 43,850 | +58.3% | 0.00% | – |
| Q2 2021 | $596,000 | +17.8% | 27,707 | +238.0% | 0.00% | – |
| Q1 2021 | $506,000 | -69.0% | 8,198 | -79.0% | 0.00% | – |
| Q4 2020 | $1,634,000 | – | 39,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |